The Breast Cancer Research Foundation

BCRF 2011 Symposium, New York, NY

BCRF 2011 Symposium, Palm Beach

February 2011

BCRF 2010 Symposium, NYC

BCRF Symposium and Awards Luncheon
October 27, 2010
Waldorf=Astoria, New York City, NY

BCRF 2010 Symposium, Palm Beach

BCRF 2007 Symposium, NYC

"Starve a cancer, stop its growth: Advances in anti-angiogenesis"

The Breast Cancer Research Foundations 2007 Symposium in New York City focused on angiogenesis: the very word is daunting. But break it down and it becomes a fundamental concept for understanding how tumors grow so well—stronger and faster even than the bodys normal cells. "Angio-," which stands for blood vessel, and "genesis," meaning new, or beginning, combine to explain a process that occurs in health and in a lot of diseases, including breast cancer.

Distinguished Panel:
Robert Benezra, PhD, Memorial Sloan-Kettering Cancer Center
Laura Esserman, MD, MBA, Univ. of California/San Francisco Comprehensive Cancer Center
Nancy Davidson, MD, Director of the University of Pittsburgh Cancer Institute
Judah Folkman, MD (since deceased) Childrens Hospital, Boston
Kathy Miller, MD, Indiana University School of Medicine
George Sledge, MD, Indiana University School of Medicine
Moderated by Larry Norton, MD, Memorial Sloan-Kettering Cancer Center, Scientific Director and Chairman, BCRF Executive Board of Scientific Advisors

BCRF 2008 Symposium, NYC

"Not all cancers are alike: identifying the cells that grow into cancers and what we can do about them."

The Breast Cancer Research Foundations 2008 Symposium in New York City addressed this important and emerging aspect of breast cancer. "Not all cancer cells are alike" can be taken in two ways. In the scientific sense, breast cancer is being parsed into more and more subcategories. In another sense, the odds for surviving breast cancer have improved dramatically in the past fifteen years. The chances for survival are better for breast cancer than for other common cancers such as lung or ovarian cancer.

Distinguished Panel:
Joan S. Brugge, PhD, Harvard Medical School
Michael F. Clarke, MD, Stanford University School of Medicine
Charlotte Kuperwasser, PhD, Tufts University School of Medicine
Hope S. Rugo, MD, University of California, San Francisco
Robert A. Weinberg, PhD, Whitehead Institute for Biomedical Research
Moderated by Larry Norton, MD, Memorial Sloan-Kettering Cancer Center, Scientific Director and Chairman, BCRF Executive Board of Scientific Advisors